Abstract: The present invention relates to a diet product comprising an alginate in an aqueous dissolved or swelled form at a pH value causing the alginate not to gel.
Abstract: A pharmaceutical composition including an alkaline metal alginate, an alkaline salt, and less than 10% by weight based on the weight of the alkaline metal alginate of a calcium salt. The pharmaceutical composition is intended for the treatment or prophylaxis of dyspepsia in a mammal.
Abstract: The present invention relates to a diet product comprising an alginate in an aqueous dissolved or swelled form at a pH value causing the alginate not to gel.